Two O&P items on socket sensing arrived the same day. They're describing different parts of the same problem.

Two separate items in The O&P EDGE landed on August 17 and addressed the same underlying problem: the persistent difficulty of knowing what a prosthetic socket is actually doing to a residual limb during a full day of wear. One described a research result from Purdue University and the University of Notre Dame — a prosthetic socket interface using embroidered, light-emitting textiles that can map normal and shear forces simultaneously across the socket-skin boundary. The other announced that Hanger Ventures, the investment arm of the largest O&P provider network in the United States, had backed Prosthetic Fit 360, maker of a continuous socket fit monitoring system called Limn Fit.

These look like the same story. They are not.

They address the same gap from different angles, using different approaches, funded by different kinds of capital, at different distances from a clinical appointment. Understanding what each is actually doing — and what neither is doing — is more useful than treating them as interchangeable news about “socket sensing technology.”

The problem neither announcement is exaggerating

The socket is the functional foundation of a prosthesis. The information currently available to a prosthetist about what that socket is doing during the hours someone actually uses it is remarkably thin.

The clinical baseline is patient report and post-hoc skin inspection. A patient describes where it is uncomfortable; the prosthetist examines the skin after doffing and adjusts. This works when the problem is consistent and easy to locate. It works less well when the discomfort appears during ambulation and resolves before the appointment. It doesn’t capture where load is highest during the third hour of a workday, whether the fit is adequate at 8 a.m. and marginal by 4 p.m., or whether the forces causing early skin damage are primarily compressive or include shear loading at a specific site.

Both announcements are aimed at that gap. What they’re doing about it is substantially different.

What the Purdue–Notre Dame research is actually solving

The academic work focuses on what to measure and how — specifically, a sensing architecture that can detect both normal force (compressive, perpendicular to the socket wall) and shear force (lateral, occurring when the residual limb moves relative to the socket wall during gait) across the whole interface surface simultaneously.

Shear is the harder problem. Normal force has been measurable at discrete points in research sockets for years. Shear acts across a surface, in multiple directions, on a substrate that is soft, wet, irregular, and moving — and a rigid sensor array that measures shear force will alter the fit it is trying to measure. The Purdue–Notre Dame approach addresses this by integrating the sensor into the textile itself: light-emitting threads embroidered into the interface material illuminate the structure and detect mechanical changes in how light moves through it. The result is a distributed sensor that conforms to the surface rather than sitting against it as a separate element.

The clinical significance of shear: it is implicated in soft-tissue damage at loading levels that would otherwise be tolerable. Normal force alone does not predict skin breakdown well. The combination of normal and shear at the same site reduces the threshold at which injury begins. A socket that appears adequate by pressure measurement may not be adequate when shear is included — and shear distribution is something the field currently cannot measure in clinical practice.

What this research provides, even as a research instrument, is a more complete empirical picture of what happens at the socket interface during real activity. Where this research sits on the pipeline: it is a materials science and engineering result demonstrated in a controlled setting. Manufacturing compatibility, durability in daily use conditions, and the regulatory pathway all remain. The distance between this result and a clinically deployable product is measured in years and several development milestones. The full analysis is here.

What the Hanger Ventures investment is actually doing

The Hanger announcement is a different kind of bet. Hanger Ventures isn’t betting on a sensing architecture — it’s betting on a company positioned to build a product for clinical deployment, and the investor is itself the potential distribution channel.

Hanger Inc. operates over 800 patient care clinics. When Hanger Ventures backs a socket sensing startup, the investment carries an implicit infrastructure claim: if Prosthetic Fit 360 builds something that works and can be integrated into clinical workflows, Hanger has both the scale and the incentive to deploy it. That is a meaningfully different position than a general venture fund making a bet on medical device technology.

What Limn Fit actually does — the specific sensing architecture, where the sensors sit in the socket system, what the data output looks like, how a prosthetist interacts with it — is not detailed in the announcement. “Continuous, data-driven insights into prosthetic socket fit” describes an intended capability. The technical implementation of that capability is not public.

What the investment does not do is guarantee a timeline or a deployment. Between a venture announcement and a sensing system appearing in a clinical appointment runs the usual sequence: product development, clinical studies, workflow integration, training, and a coverage determination — whether continuous socket monitoring is billable as a distinct service, bundled into the fitting visit, or borne by the clinic as a practice investment. That sequence has stopped many O&P technology products that demonstrated promise in controlled settings. Hanger’s involvement changes the incentive structure around it; it doesn’t eliminate the sequence.

The full analysis of the investment and what it means for the field is here.

What the coincidence of timing actually signals

These announcements arrived in the same news cycle by coincidence, not coordination. But the coincidence is not random in the larger sense.

Socket fit sensing has been a recognized research priority for a decade. The evidence base — that fit quality drives abandonment rates, skin breakdown, falls, and functional outcomes — is established. What has been missing is the practical capacity to measure what’s happening during actual use. Academic groups have built research instruments; commercial products have been announced and not deployed; a persistent gap has stayed open between what’s known to matter and what’s measurable outside a controlled setting.

The Purdue textile and the Hanger investment are not the beginning of that development. They are two current events in a longer arc. Research is establishing what can be measured and providing the technical foundations that commercial products will eventually draw on. Commercial investment is building the product and deployment infrastructure that academic labs cannot provide. When both tracks are active in the same moment, the category is advancing — which is different from a single announcement that turns out not to move anything.

The question of when this results in a clinical appointment that’s different from today’s appointment is genuinely uncertain. Sensor technology in prosthetics has a history of longer timelines than announcements suggest. What the current activity level does indicate is that socket sensing is accumulating the kind of dual momentum — validated research plus commercial infrastructure investment — that tends to precede practical availability. Whether “tends to” translates to a specific year is the part neither announcement answers.

What this means now

Neither of these developments changes a fitting appointment next month. The Purdue textile is a research result. The Limn Fit investment describes a startup at a pre-deployment stage.

The practical question available today, before any of this technology is in a clinic, is whether the fit documentation that currently exists — socket modification logs, check-socket iteration notes, patient-reported outcome data over time, skin inspection findings — is being captured in a structured way. That information is what would anchor comparisons if continuous monitoring data becomes available: a baseline to measure against, evidence of a fit pattern over time that no single appointment can capture.

That question is answerable now, with no new technology. It often isn’t being asked. It is worth raising with your prosthetist before the appointment where sensing data would be useful.

---

This article covers prosthetic technology research and investment news and does not constitute clinical advice about socket fitting, device selection, or management of skin concerns. Technology timelines are based on publicly available announcements. Socket fit is individual and depends on clinical assessment by a certified prosthetist. If you are experiencing fit problems or skin breakdown, contact your O&P provider.